Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
abacavir/lamiVUDine/zidovudine
abacavir/lamiVUDine/zidovudine
Brand names: Trizivir
| Form | Strength |
|---|---|
| TABLET, ORAL | 300 mg-150 mg-300 mg |
Last updated: Feb. 22, 2023
- Non-Antineoplastic HD PPE and Disposal
- Non-Antineoplastic HD Hazardous Drug Safe Handling Policy
- Black Box Warning: Abacavir: Hypersensitivity reactions; lactic acidosis, hepatomegaly
- Black Box Warning: Lamivudine: Lactic acidosis, hepatomegaly; exacerbations of hepatitis b; dosing formulation
- Black Box Warning: Zidovudine: Hematological adverse events; myopathy; lactic acidosis; hepatomegaly
Non-Formulary medication